Scientific Program

  • HOME
  • PROGRAM
  • Scientific Program

March 29 (Thursday)

Oral Presentation 01

Date & Time March 29 (Thu), 08:00-09:00 Venue VISTA 1 Language English
Chairs

Chan-Jeoung Park, University of Ulsan College of Medicine, Korea

In Ho Kim, Seoul National University College of Medicine, Korea

Presentations

Immature Platelet Fraction (IPF): A Useful Marker for Evaluating the Cause of Thrombocytopenia and Predicting Platelet Recovery

Kibum Jeon, Departments of Laboratory Medicine, Hallym University Sacred Heart Hospital, Korea

Acacia Senegal Supplementation Improve Dyslipidemia in Sickle Cell Anemia Novel Effect of Gum Arabic

Lamis Kaddam, Department of Physiology, Alneelain University Faculty of Medicine, Sudan

Proof of Concept - Leukodepleted Red Blood Cells by Double Filtration Can Replace Irradiated Blood

Se Jong Chun, Department of Laboratory Medicine, Chonnam National University Medical School, Korea

Establishing of Reference Intervals for 16 Complete Blood Count Parameters in Healthy Elderly People

Eun Jin Lee, Department of Laboratory Medicine, Hallym University College of Medicine, Korea

Oral Presentation 02

Date & Time March 29 (Thu), 08:00-09:00 Venue VISTA 2 Language English
Chairs

Ki Young Kwon, Keimyung University School of Medicine , Korea

Hye Lim Jung, Sungkyunkwan University School of Medicine, Korea

Presentations

The Spectrum of Anemia in Therapy Naive Patients with Lymphoma and Myeloma from North India

Gaurav Prakash, Department of Internal Medicine, Clinical Hematology Unit, PGIMER, Chandigarh, India

Successful Treatment of Refractory Pure Red Cell Aplasia with Sirolimus

Zhangbiao Long, Department of Hematology, Peking union medical college hospital, China

Dynamics Of CMV And EBV Loads After Rabbit Atg And Cyclosporine : A Prospective Observational Study

Sung-Soo Park, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Korea

Helicobacter Pylori Testing in Patients with Pernicious Anemia

Ik Chan Song, Department of Internal Medicine, College of Medicine, Chungnam National University, Korea

Oral Presentation 03

Date & Time March 29 (Thu), 08:00-09:00 Venue VISTA 3 Language Korean
Chairs

Chul-Won Choi, Korea Universty College of Medicine, Korea

Won-Sik Lee, Inje University College of Medicine, Korea

Presentations

Treatment Outcome and Prognostic Factors of Precursor T-Acute Lymphoblastic Leukemia in Children

Hyery Kim, Department of Pediatric, University of Ulsan College of Medicine, Asan Medical Center, Korea

Allogeneic Hematopoietic Stem Cell Transplantation for Childhood Myelodysplastic Syndrome

Jae Won Yoo, Department of Pediatrics, University of Ulsan College of Medicine, Asan Medical Center Children’s Hospital, Korea

Cell Therapy to Control Relapsed AML following Allogeneic Stem Cell Transplantation

Woochan Park, Department of Internal Medicine, Seoul National University Hospital, Korea

Discrepancy in Efficacy of Disulfiram between NUP98-PHF23 Fusion Acute Myelogenous Leukemia

Eun Sil Park, Department of Pediatrics, Institute of Health Science, College of Medicine Gyeongsang National University, Genetics Branch, Center for Cancer Research , National Cancer Institute/National Institute of Health, Korea

Arsenic Trioxide-Based Initial Treatment for Acute Promyelocytic Leukemia with High-Risk Features

Gi June Min, Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, Korea

Feasibility of blinatumomab Salvage for Adult Patients with Relapsed or Refractory Ph-Negative ALL

Jae-Ho Yoon, Department of Hematology, Catholic Blood and Marrow Transplantation Center, Leukemia Research Institute, Seoul St. Mary’s Hospital, The Catholic University of Korea , Korea

Educational Session 01

Multiple Myeloma

Date & Time March 29 (Thu), 09:00-10:00 Venue VISTA 1 Language Korean
Chairs

Ki-Hyun Kim, Sungkyunkwan University School of Medicine, Korea

Jin Seok Kim, Yonsei University College of Medicine, Korea

Speakers

1. Monoclonal Gammopathy of Renal Significance

Jung Eun Lee, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

2. Smoldering Multiple Myeloma

Byung-Su Kim, Department of Laboratory Medicine, Hallym University College of Medicine

3. Next Generation Sequencing in Multiple Myeloma

Miyoung Kim, Department of Laboratory Medicine, Hallym University College of Medicine, Korea

Educational Session 02

Typical and atypical Chronic Myelogenous Leukemia

Date & Time March 29 (Thu),09:00-10:00 Venue VISTA 2 Language Korean
Chairs

Chul Won Jung, Sungkyunkwan University School of Medicine, Korea

Suk Joong Oh, Sungkyunkwan University School of Medicine, Korea

Speakers

1. Optimal First-line Treatment of Chronic Phase CML

Kyoung Ha Kim, Division of Hematology-Oncology, Department of Internal Medicine, Soonchunhyang University College of Medicine , Korea

2. Update on the Treatment of CML in Children

Jae Wook Lee, Department of Pediatrics, College of Medicine, The Catholic University of Korea, Korea

3. BCR-ABL1 Negative Hematologic Neoplasms; Diseases that are Similar to but Different from CML

Hawk Kim, Division of Hematology, Gachon University College of Medicine, Korea

Educational Session 03

Thrombotic Microangiopathy

Date & Time March 29 (Thu), 09:00-10:00 Venue VISTA 3 Language Korean
Chairs

Kyung Duk Park, Chonbuk National University Medical School, Korea

Soo-Mee Bang, Seoul National University College of Medicine, Korea

Speakers

1. Childhood aHUS

Hae Il Cheong, Department of Pediatrics, Seoul National University College of Medicine, Korea

2. Adult aHUS

Youngil Koh, Youngil Koh, Hematology & Medical Oncology, Department of Internal Medicine, Seoul National University College of Medicine, Korea

3. Management of TTP

Doyeun Oh, Department of Internal Medicine, CHA University School of Medicine, Korea

Scientific Session 01

Single Cell Genomics

Date & Time March 29 (Thu), 10:20-11:40 Venue VISTA 1 Language English
Chairs

Woong Yang Park, Sungkyunkwan University School of Medicine, Korea

Dong Soon Lee, Seoul National University College of Medicine, Korea

Speakers

1. Single Cell Genome Analysis in Human Cancers

Woong-Yang Park, Department of Molecular Cell Biology, Sungkyunkwan University School of Medicine, Korea

2. Characteristics of Tumor Infiltrating Lymphocytes Revealed by Single Cell RNA     Sequencing

Zemin Zhang, BIOPIC and School of Life Sciences, Peking University, China

3. Dissecting the Cellular and Genetic Composition of Pediatric Leukemias by Single-Cell Genomics

Charles Gawad, Department of Oncology, Department of Computational Biology, St. Jude Children's Research Hospital, USA

Scientific Session 02

(KAI-KSH JOINT) Cancer Immunology

Date & Time March 29 (Thu), 10:20-11:40 Venue VISTA 2 Language English
Chairs

Jae Hoon Lee, Gachon University College of Medicine, Korea

Chung Gyu Park, Seoul National University College of Medicine, Korea

Speakers

1. Immune Checkpoint Inhibition in Hematologic Malignancy - Focusing on Multiple Myeloma

Yoon Seok Choi, Department of Internal Medicine, Chungnam National University College of Medicine, Korea

2. A New Antigen Presenting Cell based Therapeutic Cancer Vaccine

Chang-yuil Kang, Laboratory of Immunology, College of Pharmacy, Seoul National University, Korea

3. Chimeric Antigen Receptor-Engineered Natural Killer Cell Immunotherapy for Cancer

Kyung-Nam Koh, Department of Pediatrics, University of Ulsan College of Medicine, Korea

4. Post-transplant Immunotherapy with WT1-specific CTLs for High-risk AML

Tai-Gyu Kim, Department of Microbiology, Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Korea

Oral Presentation 04

Date & Time March 29 (Thu), 11:50-12:50 Venue VISTA 1 Language English
Chairs

Byung-Su Kim, Hallym University College of Medicine, Korea

Won Seog Kim, Sungkyunkwan University School of Medicine, Korea

Presentations

Inflammatory Factor-Based Scoring System in DLBCL in the Rituximab Era

Ji Hyun Lee, Department of Internal Medicine, Dong-A University College of Medicine, Korea

Clinical Features and Treatment Outcomes of Limited State Mantle Cell Lymphoma (CISL1606)

Jae-Cheol Jo, Department of Hematology and Oncology, Ulsan University Hospital, Korea

Poor Clinical Outcome of Epstein-Barr Virus Associated Secondary Hemophagocytic Lymphohistiocytosis

Jae-Ho Yoon, Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, Korea

3.5-Yr Follow-Up of Ibrutinib-Treated Relapsed/Refractory Mantle Cell Lymphoma Pts: Pooled Analysis

Seok-Goo Cho, Department of Hematology, Seoul St. Mary’s Hospital, Korea

Oral Presentation 05

Date & Time March 29 (Thu), 11:50-12:50 Venue VISTA 2 Language English
Chairs

Jae Yong Kwak, Chonbuk National University Medical School, Korea

Seok Lee, College of Medicine, The Catholic University of Korea, Korea

Presentations

Clinical Signi cance of Secondary-Type Mutations in MDS and AML

Joon-Ho Moon, Department of Hematology and Oncology, Kyungpook National University Hospital, Korea

Comparable Outcomes of RIC to MAC-HCT by MRD Kinetics in Adults with Ph-Positive ALL in CR1

Jae-Ho Yoon, Department of Hematology Catholic BMT Center, Leukemia Research Institute, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Korea

Comprehensive Analysis of Genetic Variations in Patients with Acute Lymphoblastic Leukemia

Borahm Kim, Department of Laboratory Medicine, Yonsei University College of Medicine, Korea

Molecular Scoring System integrated with IPSS-R in Korean Myelodysplastic syndrome

Hee Sue Park, Department of Laboratory Medicine, Seoul National University College of Medicine, Korea

Oral Presentation 06

Date & Time March 29 (Thu), 11:50-12:50 Venue VISTA 3 Language English
Chairs

Joon Seong Park, Ajou University School of Medicine, Korea

Keon Hee Yoo, Sungkyunkwan University School of Medicine, Korea

Presentations

Decitabine Versus Intensive Chemotherapy for Induction Treatment of Elderly Patients with AML

Eun-Ji Choi, Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Korea

The Role of WT-1 as a Potential Marker to Predict Prognosis and Monitor Minimal Residual Disease

Seung-Hwan Shin, Department of Hematology, Yeouido St. Mary’s Hospital, The Catholic University of Korea, Korea

Prognostic Factors in Children with Core Binding Factor Acute Myeloid Leukemia

Jae Wook Lee, Department of Pediatrics, , The Catholic University of Korea, Korea

Registry-Based Study of Hematopoietic Stem Cell Transplantation in Korean Children

Hee Young Ju, Department of Center for Pediatric Cancer, National Cancer Center, National Cancer Control Institute, Korea

[Luncheon] Satellite Symposium 01

KYOWA KIRIN

Date & Time March 29 (Thu), 13:00-14:00 Venue VISTA 1 Language English
Chairs

Cheol Won Suh,University of Ulsan College of Medicine, Korea

Speakers

Updated Febrile Neutropenia Management

Won Seog Kim, Sungkyunkwan University School of Medicine, Korea

[Luncheon] Satellite Symposium 02

NOVARTIS

Date & Time March 29 (Thu), 13:00-14:00 Venue Room B Language English
Chairs

Dong-Wook Kim, College of Medicine, The Catholic University of Korea, Korea

Speakers

It's Time We Go Deeper

Pierre Laneuville, McGill University Health Centre Montreal, Canada

[Luncheon] Satellite Symposium 03

HANDOK

Date & Time March 29 (Thu), 13:00-14:00 Venue Room C Language English
Speakers

Complement Mediated Glomerular Disease(Focusing on aHUS): Everything has Changed in the Last 10 Years but Still a Lot to Do

Giuseppe Remuzzi, Mario Negri Institute for Pharmacological Research, Italy

Plenary Lecture 01

Precision Hematology in Genomics Era

Date & Time March 29 (Thu), 14:00-15:20 Venue VISTA Language English
Chairs

Yoo-Hong Min, Yonsei University College of Medicine, Korea

Sun Hee Kim, Sungkyunkwan University School of Medicine, Korea

Speakers

1. Precision Medicine in CLL

Constantine Tam, Peter MacCallum Cancer Centre, St Vincent’s Hospital and University of Melbourne, Australia

2. The Clinical Management of FLT3-Mutated AML

Mark Levis, Johns Hopkins School of Medicine, USA

EHA-KSH Joint Symposium 01

Myelodysplastic Syndrome

Date & Time March 29 (Thu),15:40-17:00 Venue VISTA 1, 2 Language English
Chairs

Je-Hwan Lee, University of Ulsan College of Medicine, Korea

Valeria Santini, University of Florence, Italy

Speakers

1. The Best Prediction of Prognosis for MDS: How to Integrate Clinical and Molecular Data

Valeria Santini, University of Florence, Italy

2. Clinical Effects of Somatic Mutations in MDS

Je-Hwan Lee, University of Ulsan College of Medicine, Korea

3. Pathogenesis and Management of CMMoL

Raphael Itzykson, Department of Hematology, Paris Diderot University, France

4. Hypomethylating Therapy in Stem Cell Transplantation for MDS

Yoo-Jin Kim, Department of Hematology, College of Medicine, The Catholic University of Korea, Korea

Special Report 01

Updates on Cellular therapies

Date & Time March 29 (Thu),15:40-17:00 Venue VISTA 3 Language English
Chairs

Ulrike Kohl, Hannover Medical School. Germany

Tai-Gyu Kim, Catholic Hematopoietic Stem Cell Bank, College of Medicine, The Catholic University of Korea, Korea

Speakers

1. CAR T Treatment for ALL

Jae Park, Memorial Sloan Kettering Cancer Center (MSKCC), USA

2. CAR Expressing Effector Cells in Stem Cell Transplantation

Ulrike Kohl, Hannover Medical School, Germany

3.Ex Vivo T cell-depleted Haploidentical Hematopoietic Cell Transplantation and Cellular Therapy Post-transplantation

Ho Joon Im, Department of Pediatrics, University of Ulsan College of Medicine, Korea

Oral Presentation 07

Date & Time March 29 (Thu), 17:10-18:10 Venue VISTA 1 Language English
Chairs

Jong Ho Won, Soon Chun Hyang University College of Medicine, Korea

Joo Seop Chung, Pusan National University College of Medicine, Korea

Presentations

The Clinical Outcomes of Lenalidomide and Dexamethasone in Patients with Relapsed Multiple Myeloma

Ho Sup Lee, Department of Internal Medicine, Kosin University College of Medicine, Korea

Prognostic Significance of Clonal Evolution by Bone Marrow Cytogenetic Analysis in Multiple Myeloma

Chang Ahn Seol, Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Korea

3-Methyladenine Potentiates Apoptosis of Myeloma Cells via Mitochondrial Reactive Oxygen Species

Yeung-Chul Mun, Department of Hematology, Ewha Womans University, Korea

The Safety and Efficacy of Pomalidomide in Combination with Cyclophosphamide and Dexamethasone (PCD)

Ho Sup Lee, Department of Internal Medicine, Kosin University College of Medicine, Korea

Oral Presentation 08

Date & Time March 29 (Thu), 17:10-18:10 Venue VISTA 2 Language English
Chairs

Seong Kyu Park, Soon Chun Hyang University Hospital Bucheon, Korea

Yoo-Jin Kim, College of Medicine, The Catholic University of Korea, Korea

Presentations

Mitochondrial Genomic Analysis in Patients with Myelodysplastic Syndromes and Other Myeloid Malignan

Seon Young Kim, Department of Laboratory Medicine, Chungnam National University School of Medicine, Chungnam National University Hospital, Cancer Research Institute, Korea

Comprehensive Genomic Analyses of Core-Binding Factor AML from Serial Samples

Taehyung Kim, Department of Computer Science, University of Toronto, The Donnelly Centre for Cellular and Biomolecular Research, Canada

TET2 and MicroRNA-22 in Myelodysplastic Syndrome Patients who Received Hypomethylating Agents

Se Hyung Kim, Department of Internal Medicine, Division of Hemato-Oncology, Soonchunhyang University Bucheon Hospital, Korea

Oral Presentation 09

Date & Time March 29 (Thu), 17:10-18:10 Venue VISTA 3 Language English
Chairs

June-Won Cheong, Yonsei University College of Medicine, Korea

Sung-Hyun Kim, Dong-A University College of Medicine, Korea

Presentations

Evaluate the Effect of Imatinib in Treatment Chronic Myeloid Leukemia in Children.

Quoc Thanh Nguyen, Department of Hematology, University of Medicine and Pharmacy in Ho Chi Minh city , 2nd Pediatric, Blood Transfusion and Hematology in Ho Chi Minh city, Ha Noi Medical University, Vietnam

Evaluation of 10-Year Imatinib's Treatment Effects on Chronic Myeloid Leukemia in Chronic Phase

Nguyen Phuong Dung Co, Department of Hematology, Pham Ngoc Thach Medical University, Ha Noi Medical University, Blood Transfusion and Hematology in Ho Chi Minh city, Vietnam

The Significance of Very Early Molecular Response with Frontline Dasatinib Treatment in CML Patients

Won-Sik Lee, Department of Internal Medicine, Inje University Busan Paik Hospital, Korea

Deeper Molecular Response in Newly Diagnosed CML-CP Patients Receiving Radotinib: RERISE 3 Years FU

Youngrok Do, Department of Hematology and Oncology, Department of Medicine, Dongsan Medical Center, Keimyung University, Korea

March 30 (Friday)

Oral Presentation 10

Date & Time March 30 (Fri), 08:00-09:00 Venue VISTA 1 Language English
Chairs

Young-Ho Lee, Hanyang University College of Medicine, Korea

Ki-Seong Eom, College of Medicine, The Catholic University of Korea, Korea

Presentations

Gene Spectrum Analysis of Thalassemia Carriers Residing in Northern China

Wenzhe Zhou, Department of Hematology, Peking Union Medical Collage, Chinese Academe of Medical Science, China

Comparison of Gene Spectrum of Thalassemia in Northern, Southern China and Southeast Asia

Quexuan Cui, Department of Hematology, Peking Union Medical Collage Hospital, Chinese Academe of Medical Science, China

ThalPred: A Web-Based Decision Making Tool for Discriminating Thalassemia Trait and Iron Deficiency

Pornlada Nuchnoi, Department of Clinical Microscopy, Faculty of Medical Technology, Mahidol University, Thailand

Epidemiology of Hereditary Hemolytic Anemia for 10 Years (2007-2016): RBC Disorder WP Study

Ye Jee Shim, Department of Pediatrics, Keimyung University School of Medicine and Dongsan Medical Center, Korea

Oral Presentation 11

Date & Time March 30 (Fri), 08:00-09:00 Venue VISTA 2 Language English
Chairs

Seok-Lae Chae, College of Medicine, Dongguk University, Korea

Dae-Chul Jeong, College of Medicine, The Catholic University of Korea, Korea

Presentations

Nutritional Iron Deficiency Anemia: Magnitude and Its Predictors among School Age Children, Southwest, Ethiopia

Amare Desalegn Wolide, Department of Biomedical Sciences, Jimma University, Ethiopia

Prevalence of Inherited Hemoglobin Disorders and Relationships with Anemia and Micronutrient Status

Yannick Oyono, Department of Medical Labortory Sciences, University of Buea, Centre Pasteur, Cameroon

Impact of Thrombocytopenia on In-Hospital Outcome in Patients with Acute STEMI

Ru Liu, Department of Cardiology, Fuwai Hospital, National Center for Cardiovascular Diseases, China

Important Factors to Increase the Survival in Hemophilia Patient with Life-Threatening Hemorrhage

Kun Soo Lee, Department of Pediatrics, Kyungpook National University School of Medicine, Korea

Oral Presentation 12

Date & Time March 30 (Fri), 08:00-09:00 Venue VISTA 3 Language Korean
Chairs

Ho Jin Shin, Pusan National University Hospital, Korea

Seonyang Park, Inje University College of Medicine, Korea

Presentations

Comparison of Outcomes between Unrelated Donor and Haploidentical Transplantation in Aplastic Anemia

Sung Soo Park, Department of Hematology, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Korea

Role of FDG PET for Evaluation of Bone Marrow Status and Prognosis Prediction in T-Cell Lymphomas

Go-Un Woo, Department of Internal Medicine, Seoul National University Hospital, Korea

Nutritional Status and Cardiovascular Risk Factors Affect Survival of DLBCL

Ji Hyun Lee, Department of Internal Medicine, Dong-A University College of Medicine, Korea

Experience of Levetiracetam for Prevention of Busulfan-Induced Seizures in Adult HSCT Patients

Soo-Jeong Kim, Department of Internal Medicine, Yonsei University College of Medicine, Korea

Clinical Factors to Predict the Engraftment in Low CD34 Count Autologous Stem Cell Transplantation

Sang-A Kim, Department of Internal Medicine, Seoul National University Hospital, Korea

Efficacy and Safety of Bendamustine Plus Rituximab as Early Salvage Treatment in Relapsed/Refractory

Young-Woo Jeon, Department of Hematology, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary’s Hospital, Korea

Scientific Session 03

Recent Advances in Acute Promyelocytic Leukemia

Date & Time March 30 (Fri), 09:00-10:20 Venue VISTA 1 Language English
Chairs

Hee-Je Kim, College of Medicine, The Catholic University of Korea, Korea

Lionel Ades, Hôpital Saint-Louis, Paris Diderot University, France

Speakers

1. JALSG Prospective Study for APL

Akihiro Takeshita, Transfusion and Cell Therapy, Hamamatasu University School of Medicine, Japan

2. Therapy of APL

Lionel Ades, Hôpital Saint-Louis, Paris Diderot University, France

3. Strategies to Define High-risk Patients in APL

Byung-Sik Cho, Division of Hematology, Department of Internal Medicine, College of Medicine, The Catholic University of Korea, Korea

Scientific Session 04

Recent Advances in Natural Killer T-cell Lymphoma

Date & Time March 30 (Fri), 09:00-10:20 Venue VISTA 2 Language English
Chairs

Seok-Goo Cho, College of Medicine, The Catholic University of Korea, Korea

Wee Joo Chng, National University Cancer Institute, Singapore

Speakers

1. Molecular Pathogenesis of NKTL

Wee Joo Chng, National University Cancer Institute, Singapore

2. Current Standard Treatment of ENKTL

Yok Lam Kwong, University of Hong Kong, Hong Kong

3. Beyond Current Standard Care of ENKTL

Won Seog Kim, Division of Hematology-Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Oral Presentation 13

Date & Time March 30 (Fri), 09:00-10:00 Venue VISTA 3 Language English
Chairs

Myungshin Kim, College of Medicine, The Catholic University of Korea, Korea

Jin Yeong Han, Dong-A University College of Medicine, Korea

Presentations

Quality of Life in Patients with Type I Gaucher Disease after Long Term Enzyme Replacement Therapy

Hongmin Li, Department of Hematology, Peking Union Medical College Hospital, China

Hematological Finding and Clinical Profile in Pulmonary Tuberculosis among HIV Patients

Petrus Kanisius Yogi Hariyanto, Department of Medicine, Faculty of Medicine, Udayana University, Indonesia

Cefepime Versus Cefepime Plus Amikacin For Febrile Neutropenia In Pediatric Cancer Patients

Na Hee Lee, Department of Pediatrics, Cha Bundang Medical Center, Cha University, Korea

Detection of Bacteremia MRSA Using a Novel Isothermal Amplification with SPR Biosensor Methodology

Zhenbo Xu, Department of Microbial Pathogenesis, School of Food Sciences and Engineering, South China University of Technology, Guangdong Province Key Laboratory for Green Processing of Natural Products and Product Safety, School of Dentistry, University of Maryland, China

Plenary Lecture 02

Targeting Leukemic Stem Cells

Date & Time March 30 (Fri), 10:30-11:50 Venue VISTA Language English
Chairs

Hyeoung-Joon Kim, Chonnam National University Medical School, Korea

Dong-Wook Kim, College of Medicine, The Catholic University of Korea, Korea

Speakers

1. Human Myeloid Leukemia Stem Cells

Koichi Akashi, Department of Medicine and Biosystemic Science, Kyushu University Graduate School of Medical Sciences, Japan

2. Pre-Cancerous Stem Cells in MDS and AML: Significance, Mechanisms, and Therapeutic Targeting

Ulrich Steidl, Department of Cell Biology, and Department of Medicine, Albert Einstein College of Medicine, USA

[Luncheon] Satellite Symposium 04

AMGEN

Date & Time March 30 (Fri), 12:00-13:00 Venue VISTA 1 Language English
Chair

Chang-Ki Min, College of Medicine, The Catholic University of Korea, Korea

Speakers

Treatment of Multiple Myeloma in Relapse

Keith Stewart, Mayo Clinic, USA

[Luncheon] Satellite Symposium 05

BMS

Date & Time March 30 (Fri), 12:00-13:00 Venue VISTA 2 Language English
Chair

Dong-Wook Kim, College of Medicine, The Catholic University of Korea, Korea

Speakers

Emerging Trends in CML Management

Elias Jabbour, Leukemia Department, MD Anderson Cancer Center, USA

[Luncheon] Satellite Symposium 06

HANDOK

Date & Time March 30 (Fri), 12:00-13:00 Venue VISTA 3 Language English
Chair

Jong Wook Lee, College of Medicine, The Catholic University of Korea, Korea

Speakers

HSCT Early Complications: Focus on Severe Hepatic Veno-occlusive Disease;- The Revised EBMT Diagnostic and Severity Criteria for Adults and an Update on Defibrotide

Mohamad Mohty, Clinical Hematology and Cellular Therapy Dpt., Sorbonne University, Hôpital Saint-Antoine, France

Scientific Session 05

Cell Death Mechanism

Date & Time March 30 (Fri), 13:00-14:20 Venue VISTA 1 Language English
Chairs

Myung-Geun Shin, Chonnam National University Medical School, Korea

Yong Goo Kim, College of Medicine, The Catholic University of Korea, Korea

Speakers

1. Apoptotic Cell Death

Soo Youl Kim, Cancer Microenvironment Branch, Division of Cancer Biology, National Cancer Center, Korea

2. CHIP Controls Necroptosis Through Ubiquitylation- and Lysosome-dependent Degradation of RIPK3

Jaewhan Song, Department of Biochemistry, Yonsei University, Korea

3. Functional Isolation of New Modulators in Apoptosis and Necroptosis

Yong-Keun Jung, Biological Sciences, Seoul National University, Korea

Scientific Session 06

Bone Marrow Failure syndrome

Date & Time March 30 (Fri), 13:00-14:20 Venue VISTA 2 Language English
Chairs

Ki Woong Sung, Sungkyunkwan University School of Medicine, Korea

Danielle Townsley, Clinical Development – Oncology, Medimmune LLC, USA

Speakers

1. Non-Transplant Therapy for Bone Marrow Failure

Danielle Townsley, AstraZeneca Medimmune, USA

2. Role of Microenvironment and Genetics in BM Failure

Myungshin Kim, Department of Laboratory Medicine, College of Medicine, The Catholic University of Korea, Korea

3. Inherited BM Failure Syndrome

Hoon Kook, Department of Pediatrics, Chonnam National University Medical School, Korea

Scientific Session 07: KOGO-KSH

Cancer Genomics

Date & Time March 30 (Fri), 13:00-14:20 Venue VISTA 3 Language English
Chairs

Sung-Soo Yoon, Seoul National University College of Medicine, Korea

Hyoung-Pyo Kim, Yonsei University College of Medicine, Korea

Speakers

1. Variability in Chromatin Architecture and Associated DNA Repair at Genomic Positions Containing Somatic Mutations

Seon-Young Kim, Gene Editing Research Center, Korea Research Institute of Bioscience & Biotechnology (KRIBB), Korea

2. Deciphering the Cell-of-Origin Harboring Driver Mutations in Brain Tumors

Jeong-Ho Lee, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology (KAIST), Korea

3. Contribution of Germline Variants in Pan-Cancer Development

Youngil Koh, Department of Internal Medicine, Seoul National University Hospital, Korea

4. Developing a Genetic Data based Prognostic Model for Hematologic Cancer

SeungHyun Jung, Cancer Evolution Research Center, College of Medicine, The Catholic University of Korea, Korea

Explore Deep Inside the Asian Hematology Network

Explore Deep Inside the Asian Hematology Network

Date & Time March 30 (Fri), 14:40-15:40 Venue VISTA 1, 2 Language English
Chairs

Seishi Ogawa,Graduate School of Medicine, Kyoto University, Japan
Hwi-Joong Yoon, Kyung Hee University College of Medicine, Korea

Speakers

AML Prognosis based on Clinical and Genomic Data

Hyeoung-Joon Kim, Department of Internal Medicine, Chonnam National University Medical School, Korea

A Novel Mechanism of Cancer Immune Evasion Via the Disruption of PD-L1 3’-UTR

Seishi Ogawa, Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Japan

Satellite Symposium 07

ROCHE

Date & Time March 30 (Fri), 14:40-15:40 Venue VISTA 3 Language English
Chairs

Won Seog Kim, Sungkyunkwan University School of Medicine, Korea

Speakers

Advancing Value-Based Approaches in the Treatment of Non-Hodgkin Lymphoma (NHL): Contemporary Strategies and Innovations

Hyeon-seok Eom, National Cancer Center, Korea

EHA-KSH Joint Symposium 02

Aplastic Anemia - Aplastic Anemia/Paroxysmal Nocturnal  Hemoglobinuria

Date & Time March 30 (Fri), 15:40-17:00 Venue VISTA 1, 2 Language English
Chairs

Hoon Kook, Department of Pediatrics, Chonnam National University Medical School, Korea
Anita Hill,St. James’ University Hospital, UK

Speakers

1. Diagnosis and Management of AA and Refractory Cytopenia of Childhood

Ayami Yoshimi, University of Freiburg, Germany

2. Frontline Alternative Donor SCT versus Immunosuppressive Treatment for Children with Severe AA who Lack Matched Related Donor

Hyoung Jin Kang, Department of Pediatrics, Seoul National University College of Medicine, Korea

3. An Update on the Management of PNH

Anita Hill, Department of Haematology, St. James's University Hospital, UK

4. Clinical Implications of Renal Dysfunction in Patients with PNH

Jin Seok Kim, Department of Internal Medicine, Yonsei University College of Medicine, Korea

Special Report 02

Multiple Myeloma Niche

Date & Time March 30 (Fri), 15:40-17:00 Venue VISTA 3 Language English
Chairs

Robert Orlowski, The University of Texas MD Anderson Cancer Center (MDACC), USA

Je-Jung Lee, Department of Hematology-Oncology, Chonnam National University Medical School, Korea

Speakers

1. Clinical Implications of MRD in Multiple Myeloma

Wee Joo Chng, National University Cancer Institute, Singapore

2. The Ubiquitin-Proteasome Pathway : Friend and Foe in Multiple Myeloma

Robert Orlowski, The University of Texas MD Anderson Cancer Center (MDACC), USA

3. Cellular Immunotherapy in Multiple Myeloma

Je-Jung Lee, Department of Hematology-Oncology, Chonnam National University Medical School, Korea

Best Abstract Presentation

Date & Time March 30 (Fri), 17:10-17:50 Venue VISTA 1,2 Language English
Chairs

Hwi-Joong Yoon, Kyung Hee University College of Medicine, Korea

Speakers

RAG1 High Expression Associated with IKZF1 Dysfunction in B-cell Acute Lymphoblastic Leukemia

Zheng Ge, Zhongda Hospital, Medical School of Southeast University, China

Decision Supporting Tool for Thrombotic Microangiopathy Based on Machine Learning Technique

Youngil Koh, Department of Internal Medicine, Seoul National University Hospital, Korea

Aberrant ARID5Bexpression and IKAROS Regulation in ALL

Chunhua Song,Department of Pediatrics, Pennsylvania State University Medical College, USA

Satellite Symposium 08

TAKEDA

Date & Time March 30 (Fri), 17:10-17:50 Venue VISTA 3 Language English
Chairs

Jae Hoon Lee, Gachon University College of Medicine, Korea

Speakers

Novel Treatment Strategies for Multiple Myeloma: A Focus on Oral Proteasome Inhibitors

Antonio Palumbo, Distinguished Research Fellow Oncology, Takeda Pharmaceuticals International AG, Italy

March 31 (Saturday)

Oral Presentation 14

Date & Time March 31 (Sat), 08:30-09:30 Venue VISTA 1 Language English
Chairs

Deog Yeon Jo, Chungnam National University College of Medicine, Korea

Chuhl Joo Lyu, Yonsei University College of Medicine, Korea

Speakers

Comparative Study of Porcine ALG and Rabbit ATG as a First-Line Treatment of Severe Aplastic Anemia

Miao Chen, Department of Hematology, Peking Union Medical College Hospital, China

PIGA Mutations as a Predictors of Treatment Response in PNH

Hee Sue Park, Department of Laboratory Medicine, Seoul National University College of Medicine, Korea

Prognostic Implications of Renal Dysfunction in Korean Patients with PNH

Jin Seok Kim, Department of Internal Medicine, Division of Hematology, Severance Hospital, Yonsei University College of Medicine, Korea

Dynamics of PNH Clone in Adult Patients with PNH/aplastic Anemia Following Immunosuppressive Therapy

Sung-Soo Park, Catholic Blood and Marrow Transplantation Center, Catholic Blood and Marrow Transplantation Center, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Korea

Oral Presentation 15

Date & Time March 31 (Sat), 08:30-09:30 Venue VISTA 2 Language English
Chairs

Hong Ghi Lee, Konkuk University School of Medicine, Korea

Deok Hwan Yang, Chonnam National University Medical School, Korea

Speakers

Analysis of Genetic Variants Related to the Hepatic Veno-Occlusive Disease in Pediatric Patients Receiving HSCT with Targeted Dose Busulfan Based Conditioning

Jung Yoon Choi, Department of Pediatrics, Cancer Research Institute, Seoul National University College of Medicine, Korea

Enhanced Immunosuppressive Properties of Human Mesenchymal Stem Cells Primed by Inflammatory Stimuli

Dae Seong Kim, Department of Pediatrics, Stem Cell and Regenerative Medicine Institute for Future Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea

Ruxolitinib Treatment for Steroid-Refractory Graft-Versus-Host Disease

Han-Seung Park, Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Korea

Change of Gut Bacterial Diversity by Antibiotics Correlates with the Occurrence of Intestinal GVHD

Chang-Ki Min, Department of Hematology, Department of Hematology, Seoul St. Mary’s Hospital, The Catholic University of Korea, College of Medicine, Korea

Oral Presentation 16

Date & Time March 31 (Sat), 08:30-09:30 Venue VISTA 3 Language Korean
Chairs

Hyeon Jin Park, National Cancer Center, Korea

Seongsoo Jang, University of Ulsan College of Medicine, Korea

Speakers

Mean Platelet Volume and Platelet Distribution Width Reflect the Pathophysiology of ITP and ET

Eunyup Lee, Department of Laboratory Medicine, Hallym University Sacred Heart Hospital, Korea

Clinical Features and Outcomes of Borderline Thrombocytopenia: A Single Center Experience

Ik Chan Song, Department of Internal Medicine, College of Medicine, Chungnam National University, Korea

Genetic Confirmation of Platelet Function Disorders by Diagnostic Exome Sequencing (K-PHOG Study)

Ye Jee Shim, Department of Pediatrics, Keimyung University School of Medicine and Dongsan Medical Center, Korea

Hot-Line to Increase the Survival in Hemophilia Patient with Life-Threatening Hemorrhage

Kun Soo Lee, Department of Pediatrics, Kyungpook National University School of Medicine, Korea

Effect of Peramivir on Platelet Counts in Patients with Suspected or Confirmed Influenza Infection

Young-Gon Kim, Department of Laboratory Medicine, Korea University Medical Center, Korea

Immature Platelet Fraction as a Predictor of Bone Marrow Cellularity in Thrombocytopenic Patients

Ha Jin Lim, Department of Laboratory Medicine, Chonnam National University Medical School and Chonnam National University Hwasun Hospital, Korea

Scientific Session 08

Current Progress in Pediatric Acute Leukemia

Date & Time March 31 (Sat), 09:30-10:50 Venue VISTA 1 Language English
Chairs

Stephen Hunger, Children's Hospital of Philadelphia, USA

Ho Joon Im, University of Ulsan College of Medicine, Asan Medical Center, Korea

Speakers

1. New Developments in the Treatment of Newly Diagnosed and Relapsed ALL

Stephen Hunger, Children's Hospital of Philadelphia, USA

2. Therapy Optimization in Infant ALL

Daisuke Tomizawa, National Center for Child Health and Development, Japan

3. Genomic Landscape and Therapy Optimization of Pediatric Mixed Phenotype Acute Leukemia

Hiroto Inaba, St. Jude Children's Research Hospital, USA

Scientific Session 09

Detetion of Minimal Residual Disease in Hematologic Malignancy

Date & Time March 31 (Sat), 09:30-10:50 Venue VISTA 2 Language English
Chairs

Hee Young Shin, Seoul National University College of Medicine, Korea

Alberto Orfao, University of Salamanca (USAL), Spain

Speakers

1. MRD Detection in Acute Leukemia, CLL and Multiple Myeloma

Alberto Orfao, University of Salamanca (USAL), Spain

2. NGS-based Assessment of Clonality & MRD Determination in ALL

In-Suk Kim, Department of Laboratory Medicine, Pusan National University Yangsan Hospital, Korea

3. [Selected Short Talk I] Development and Preliminary Evaluation of Customized Pan-Blood Cancer NGS Panel

Jun Hyung Lee, Department of Laboratory Medicine, Chonnam National University Medical School, Chonnam National University Hwasun Hospital, Korea

4. [Selected Short Talk II] Evaluation of Two Commercial Kits for Flow Cytometric MRD Detection in B-ALL

Ari Ahn, Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, Korea

Oral Presentation 17

Date & Time March 31 (Sat), 09:30-10:30 Venue VISTA 3 Language English
Chairs

Sang Kyun Sohn, Kyungpook National University School of Medicine, Korea)

Nak Gyun Chung, College of Medicine, The Catholic University of Korea, Korea

Speakers

Expression of Inhibitory Receptors on T Cells and Inhibitory Ligands on Leukemic Blasts in Childhood

Kyung-Nam Koh, Department of Pediatrics, Division of Pediatric Hematology and Oncology, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Korea

Reversal of Cytarabine Resistance in AML-OCI2 Cell Line after Na/H Exchanger 1 Modulation

June-Won Cheong, Department of Internal Medicine, Division of Hematology, Yonsei University College of Medicine, Korea

The Role of Myeloid-Derived Suppressor Cell-Like Blasts in Acute Myeloid Leukemia

Shin Young Hyun, Department of Internal Medicine, Division of Hematology and Oncology, Yonsei University Wonju College of Medicine, Korea

The Clinical Implication of Cytogenetic Clonal Evolution Pattern in Relapsed Adult ALL Patients

Ji Hyun Lee, Department of Internal Medicine, Dong-A University College of Medicine, Korea

Plenary Lecture 03

Development of Precision Medicine Trials

Date & Time March 31 (Sat), 11:10-12:30 Venue VISTA Language English
Chairs

Hong Hoe Koo, Sungkyunkwan University School of Medicine, Korea

Kyoo Hyung Lee, University of Ulsan College of Medicine, Korea

Speakers

Development of Precision Medicine Trials for ALL

Stephen Hunger, Children's Hospital of Philadelphia, USA

Progress in Therapy of Philadelphia Positive ALL

Farhad Ravandi, MD Anderson Cancer Center, USA




 

[Close]